Issue link: https://www.e-digitaleditions.com/i/1491587
38 February 2023 Inhalation in a Clinical Sample of Chil- dren. Annals of Allergy, Asthma & Immunology, Online Septem- ber 23, 2022, DOI: 10.1016/j. anai.2022.09.021. anxiety and medically unnecessary and impairing anxious avoidance related specifically to their food allergy." e study used "a group format in which children and their caregivers attended six 90-minute sessions together." In the study findings, "patients showed significant reductions on two standardized scales of anxiety: one that measures food allergy- specific anxiety (SOFAA), which was created at CHOP; and one that measures general anxi- ety (SCARED). Improvements were seen on both child-rated and parent-rated forms. Caregiv- ers also filled out satisfaction sur- veys at the end of treatment, and the results showed that 100% of caregivers found the FAB program to be 'very helpful' or 'extremely helpful' for both their children and themselves. e children and parents also reported an improve- ment in quality of life." "For children with food allergies, a little anxiety is helpful in stay- ing vigilant, but too much anxiety can prevent them from participat- ing in safe—and fun—activities that are important for their devel- opment and quality of life," said Megan O. Lewis, MSN, CRNP and co-director of the FAB Clinic. "is study shows that our Food Allergy Bravery program is a suc- cessful treatment for helping chil- dren with food allergy anxiety overcome their fears and improve their day-to-day life." References Content for this article was based on and excerpted from: • CHOP's Food Allergy Bravery Clinic Helps Kids with Food Allergies Overcome Anxiety. Sep- tember 28, 2022. https://www. prnewswire.com/news-releases/ chops-food-allergy-bravery-clin- ic-helps-kids-with-food-allergies- overcome-anxiety-301636036. html. • Dahlsgaard et al. Cognitive-Be- havioral Intervention for Anxiety Associated with Food Allergy allergen (followed by hand wash- ing), or eating a needlessly feared allergen-free food, followed by homework that involves perform- ing these tasks at home." Exposures are designed to occur "gradually, enabling children to become com- fortable being progressively closer to their allergen without having an allergic reaction." Study findings: Significant declines in anxiety A study evaluating the program's effectiveness was published in the Annals of Allergy, Asthma & Immunology in September 2022 and led by psychologist and for- mer co- director of the FAB clinic, Katherine K. Dahlsgaard, PhD. e study included ten patients, ages 8 to 12, with "confirmed IgE- mediated food allergies that were well- controlled, as well as excessive A scale to measure food allergy anxiety e Scale of Food Allergy Anxiety (SOFA A), used to measure food allergy related anxiety in children, was developed by medical profes- sionals at CHOP's Food Allergy Center and a cognitive-behavioral psychologist who specializes in pediatric anxiety, in consultation with parents of children with food allergies. Currently, there are four versions of the SOFA A. ey include a self-rated questionnaire for use with children and adolescents ages 8-18 to assess food allergy- related anxiety and related anxious avoidance behaviors over the past week. Another is a corresponding parent-rated version, in which par- ents rate their perceptions of their child's food allergy-related anxiety and anxious avoidance over the past week. A l l ver sion s a re dow n loa d- able at the following link and free to use for non-commercial r e s e a r c h a n d c l i n i c a l p u r- poses: www.chop.edu/services/ food-allergy-bravery-clinic. ADVERTISER INDEX C Catalent Pharma Solutions ... Cover 2 Copley Scientific ..............................3 D DDL ..............................................39 I Intertek ............................................5 M MKON ..........................................29 MSP, a Division of TSI ..................17 P Proveris ..........................................11 Q Qualicaps .......................................19 R RDD ...............................................1 Recipharm .......................................7 Renaissance .....................................9